» Articles » PMID: 36892108

Prospective Evaluation of the Efficacy of Inhaled Steroids Administered Via the AeroDawg Spacing Chamber in Management of Dogs with Chronic Cough

Overview
Date 2023 Mar 9
PMID 36892108
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Glucocorticoids are frequently required for management of cough because of inflammatory airway disease (IAD) and airway collapse (AWC).

Objectives/hypothesis: To determine the efficacy and feasibility of inhaled administration of corticosteroids in controlling cough in dogs with noninfectious airway disease.

Animals: Thirty-six client-owned dogs.

Methods: Dogs were prospectively recruited for this placebo-controlled cross-over study. Inflammatory airway disease was diagnosed through bronchoalveolar lavage cytology. Airway collapse was diagnosed through bronchoscopy, or if dogs were unsuitable anesthetic candidates, by crackles on auscultation, radiographic changes in airway diameter, or fluoroscopy. Dogs were randomly assigned to receive placebo or fluticasone propionate for the first 2 weeks of the trial then crossed over to fluticasone. A quality of life (QOL) survey (best score 0, worst score 85) was completed at 0 and 6 weeks. A visual-analog cough survey was submitted at 0, 2, 4, and 6 weeks to assess cough, feasibility, and adverse effects of treatment.

Results: For 32 dogs, QOL score at study end (mean 11.3 ± 9.7) was significantly lower (P < .0001) compared to entry (mean 28.1 ± 14.1), with a median change of 69% in QOL score, indicating improved quality of life. Cough frequency, duration, and severity were significantly (P < .0001) decreased at study end. Feasibility of aerosolized delivery improved with continued use (P = .05) with only 1 dog unable to accept inhaled medication.

Conclusion And Clinical Importance: This study supports the utility of fluticasone propionate by inhalation in management of cough in dogs with IAD and AWC.

Citing Articles

Use of a Capsaicin Cough Challenge Test to Compare Four Different Techniques for Nebulization Delivery in Cats.

Talavera-Lopez J, Tudela-Gonzalez A, Munoz-Prieto A Vet Sci. 2024; 11(7).

PMID: 39058004 PMC: 11281692. DOI: 10.3390/vetsci11070320.


Comparative study of the effects of antitussive drugs in a canine acute cough model.

Aoki T, Eki K Vet Med Sci. 2024; 10(5):e1549.

PMID: 39041252 PMC: 11263918. DOI: 10.1002/vms3.1549.


Comparative Study of Inhaled Fluticasone Versus Oral Prednisone in 30 Dogs with Cough and Tracheal Collapse.

Talavera-Lopez J, Saez-Mengual O, Fernandez-Del-Palacio M Vet Sci. 2023; 10(9).

PMID: 37756070 PMC: 10535501. DOI: 10.3390/vetsci10090548.


Prospective evaluation of the efficacy of inhaled steroids administered via the AeroDawg spacing chamber in management of dogs with chronic cough.

Chan J, Johnson L J Vet Intern Med. 2023; 37(2):660-669.

PMID: 36892108 PMC: 10061195. DOI: 10.1111/jvim.16673.

References
1.
Elkholly D, Brodbelt D, Church D, Pelligand L, Mwacalimba K, Wright A . Side Effects to Systemic Glucocorticoid Therapy in Dogs Under Primary Veterinary Care in the UK. Front Vet Sci. 2020; 7:515. PMC: 7457010. DOI: 10.3389/fvets.2020.00515. View

2.
Masters A, Berger D, Ware W, Langenfeld N, Coetzee J, Mochel J . Effects of short-term anti-inflammatory glucocorticoid treatment on clinicopathologic, echocardiographic, and hemodynamic variables in systemically healthy dogs. Am J Vet Res. 2018; 79(4):411-423. DOI: 10.2460/ajvr.79.4.411. View

3.
Adamama-Moraitou K, Pardali D, Day M, Prassinos N, Kritsepi-Konstantinou M, Patsikas M . Canine bronchomalacia: a clinicopathological study of 18 cases diagnosed by endoscopy. Vet J. 2010; 191(2):261-6. DOI: 10.1016/j.tvjl.2010.11.021. View

4.
Haggstrom J, Hansson K, Kvart C, Swenson L . Chronic valvular disease in the cavalier King Charles spaniel in Sweden. Vet Rec. 1992; 131(24):549-53. View

5.
Phillipps G . Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med. 1990; 84 Suppl A:19-23. DOI: 10.1016/s0954-6111(08)80003-0. View